Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease. Riley RF, Corson MA. IDrugs. 2009 Oct;12(10):648-55. PMID: 19790016 Review.

Activity: Other activity typesOther

Period2009